-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

705. Cellular Immunotherapies: Late Phase and Commercially Available Therapies: Poster II

Symposia: Cellular Immunotherapies: Late Phase and Commercially Available Therapies Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 11, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Nilu Perera, MBBS*, Ashleigh P Scott, MBBS, FRACP, FRCPA, Stewart Hunt, MBBS, FRACP, FRCPA*, Cameron Curley, MBBS, FRACP, FRCPA*, Siok-Keen Tey, MBBS, PhD, FRACP, FRCPA, Jason Butler, MBBS, FRACP, MMedSc, Andrea S Henden, BSc, MBBS, FRACP, FRCPA, PhD*, Elango S. Pillai, FRACP, FRCPA, MBBS, Cheryl Hutchins, PhD*, Kari Louise Mudie* and Glen A Kennedy, MBBS, FRACP, FRCPA*

Department of Haematology and BMT, Royal Brisbane and Women's Hospital, Brisbane, Australia

Issa F. Khouri, MD1, Hyunsoo Hwang2*, Sattva S. Neelapu, MD3, Xuemei Wang, MS2*, Chitra Hosing, MD1, Sairah Ahmed, MD4, Partow Kebriaei, MD1, May Daher, MD1, Amanda L. Olson, MD1, Paolo Anderlini, MD1, Jin S. Im, MD, PhD5, Jason Westin, MD3, Elizabeth J Shpall, MD1, Richard E Champlin, MD1 and Loretta J. Nastoupil, MD6

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Lymphoma/Myeloma and Stem Cell Transplantation, MD Anderson Cancer Center, Houston, TX
5Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas,, Houston, TX
6Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX

Stefanie Kreutmair1,2*, Maximilian M Schaefer1*, Sebastian Stolz3*, Carla Merten1*, Can Ulutekin1*, Florian Ingelfinger1*, Susanne Unger1*, Chiara Alberti1*, Tobias Wertheimer1*, Aakriti Sethi1*, Thorsten Zenz3, Markus G Manz3, Antonia Maria Susanne Müller3,4,5*, Corinne C Widmer3,5,6* and Burkhard Becher1,5*

1Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland
2German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Freiburg, Germany
3Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland
4Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria
5These authors contributed equally, Zurich, Switzerland
6Department of Hematology, University Hospital Basel, Zurich, Switzerland

Kai Rejeski, MD1, Doris K. Hansen, MD2, Radhika Bansal, MBBS3*, Pierre Sesques, MD4*, Sikander Ailawadhi5, Jennifer M. Logue, MD, BS, BA6, Ciara L. Freeman, MSc, FRCPath, MBBChir, MRCP6, Melissa Alsina, MD**7, Sebastian Theurich, MD1*, Frederick L. Locke, MD8, Emmanuel Bachy, MD, PhD4*, Michael D. Jain, MD, PhD2, Yi Lin, MD, PhD9 and Marion Subklewe, MD10

1Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
2Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
3Division of Hematology, Mayo Clinic, Rochester, MN
4Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre Benite, France
5Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL
6Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
7Moffitt Cancer Center, Tampa, FL
8Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
9Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
10Department of Medicine III (Hematology/Oncology), LMU University Hospital Munich, Muenchen, Germany

Bertram Glass1,2*, Anna Sureda3, Ariane Boumendil, PhD4*, Peter Dreger, MD5, Paolo Corradini, MD6, Ron Ram, MD7, Nicolaus Kroeger, MD8, Luca Castagna, MD9*, Thomas Pabst, MD10, Mi Kwon, MD, PhD11*, Gerald Wulf, MD12*, Alejandro Martín García-Sancho, MD, PhD13*, Carlos Solano, MD, PhD14, Matthias Stelljes, MD15, Hans Christian Reinhardt, MD16, Marie Thérèse Rubio, MD, PhD17*, Ram Malladi18*, Didier Blaise, MD, PhD19, Caroline Besley, FRCPath, PhD20*, Edouard Forcade, MD, PhD21, Malte von Bonin, MD22*, Jürgen Finke, MD, PhD23, Inken Hilgendorf, MD24*, Joaquín Martínez-López, MD, PhD25*, Jose A. Perez-Simon, MD, PhD26, Wolfgang Bethge, MD27* and Norbert Schmitz, MD28*

1Clinic for Hematology and Cell Therapy, Helios Klinik Berlin-Buch, Berlin, Germany
2EBMT Working Party Lymphoma, Paris, France
3Hematology Department, Institut Català d'Oncologia - Hospital Duran i Reynals, Barcelona, Spain
4EBMT Lymphoma Working Party Paris Office, Paris, France
5Internal Medicine V - Hematology, Oncology & Rheumatology, University of Heidelberg, Heidelberg, Germany
6Università degli Studi di Milano and Fondazione Istituti di Ricovero e Cura a Carattere Scientifico (IRCSS) Istituto Nazionale dei Tumori, Milan, Italy
7Bone Marrow Transplant Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
8Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
9Instituto Clinico Humanitas, Rozzano, MI, Italy
10University Hospital Bern, Inselspital, Bern, Switzerland
11Department of Hematology, Hospital General Universitario Gregorio Marañón, Gregorio Marañon Health Research Institute, Madrid, Spain
12Department of Hematology and Oncology, Georg-August-University of Göttingen, Göttingen, Germany
13Department of Hematology, Hospital Clínico Universitario de Salamanca, IBSAL, Salamanca, Spain
14Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain
15Dept. of Internal Medicine A, University Hospital Münster, Münster, Germany
16Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany, Essen, Germany
17Service Hématologie, CHRU Brabois, Nancy, France
18Centre for Clinical Heamatology, Queen Elizabeth Hosptial, Birmingham, United Kingdom
19Hematology Department, Institut Paoli-Calmettes, Marseille, France
20University Hospitals Bristol, Bristol, United Kingdom
21CHU Bordeaux, Hôpital Haut-Leveque, Pessac, France, Pessac, France
22Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Saxony, Germany
23Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
24Klinik für Innere Medizin II, Abt. Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Jena, Germany
25Hospital Univ. 12 de Octubre, Complutense University, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain
26Hospital Universitario Virgen del Rocio/Instituto Biomedicina Sevilla, Seville, Spain
27Hematology & Oncology, Universitaet Tuebingen, Medizinische Klinik, Tuebingen, Germany
28Department of Medicine A, University Hospital Münster, Münster, Germany

Frederick L. Locke, MD1, Zhen-Huan Hu, MPH2*, Tanya Siddiqi, MD3, Caron A. Jacobson, MD4, Sarah Nikiforow, MD, PhD4, Sairah Ahmed, MD5, David B. Miklos, MD, PhD6, Yi Lin, MD, PhD7, Matthew A. Lunning, DO, FACP8, Brian T. Hill, MD, PhD9, Armin Ghobadi, MD10, Harry Miao, MD, PhD2*, Shilpa Shahani, MD2*, Clare Spooner, MBBS, BSc2*, Christine Fu, PhD2*, Anik R. Patel, PhD2*, Hairong Xu, MD, PhD2* and Marcelo C Pasquini, MD, MS11

1Moffitt Cancer Center, Tampa, FL
2Kite, a Gilead Company, Santa Monica, CA
3Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
4Dana-Farber Cancer Institute, Boston, MA
5The University of Texas MD Anderson Cancer Center, Houston, TX
6Division of BMT and Cellular Therapy, Stanford University, Stanford, CA
7Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
8University of Nebraska, Omaha, NE
9Cleveland Clinic Foundation, Cleveland, OH
10Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
11Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI

Frederick L. Locke, MD1, Sattva S. Neelapu, MD2, Markqayne D. Ray, PharmD, MBA3*, Eve H Limbrick-Oldfield4*, Sally W Wade, MPH5*, Steve Kanters, PhD, MSc4*, Anik R. Patel, PhD3* and Olalekan O. Oluwole, MBBS6

1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
2Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX
3Kite, A Gilead Company, Santa Monica, CA
4RainCity Analytics, Vancouver, BC, Canada
5Wade Outcomes Research and Consulting, Salt Lake City, UT
6Vanderbilt University Medical Center, Nashville, TN

Maeve A O'Reilly1, Robin Sanderson2*, William Wilson3*, David Burns4*, Caroline Besley, FRCPath, PhD5*, Thomas Creasey6*, Ben Uttenthal7*, Johnathon Elliot8*, Claire Roddie1,9*, Andrea Kuhnl2*, Shankara Paneesha4, Frances Seymour10*, Sunil Iyengar11*, Lourdes Rubio12*, Matthew Wilson13, Stephen Boyle2*, Kathleen PL Cheok1, Graham P. Collins, MBBS, MA, MRCP, FRCPath, DPhil14, Rod Johnson10* and Andrew K. McMillan, MD15

1University College London Hospital NHS Foundation Trust, London, United Kingdom
2King's College Hospital, London, United Kingdom
3Cancer Research UK and UCL Cancer Trials Centre University College London, London, United Kingdom
4University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
5University Hospitals Bristol, Bristol, United Kingdom
6Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
7Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
8The Christie NHS Foundation Trust, Manchester, United Kingdom
9UCL Cancer Institute, University College London, London, United Kingdom
10Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
11Royal Marsden Hospital, London, United Kingdom
12Manchester Royal Infirmary, Manchester, United Kingdom
13Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
14Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, ENG, United Kingdom
15Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom

Viktoria Blumenberg, MD1,2,3, Galina Busch2*, Stephan Baumann2*, Regina Jitschin, PhD, MD4,5*, Michael Winkelmann, MD6*, Konstantin Hellwig, MD7*, Kai Rejeski, MD1,3,8, Lisa Frölich1,3*, Benjamin Tast1*, Christian Schmidt, MD1*, Friederike Hildebrandt, MD1*, Franziska Dekorsy, MD9*, Christian Schmidkonz, MD10*, Tobias Bäuerle, MD7*, Wolfgang G. Kunz, MD6*, Fabian Mueller, MD5,11*, Dimitrios Mougiakakos, MD4,5, Michael von Bergwelt, Prof. Dr.1,12*, Veit Bücklein, MD1,2,3*, Andreas Mackensen, MD4,5*, Simon Voelkl, PhD4,5* and Marion Subklewe, MD3,8,13

1Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
2Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany
3German Cancer Consortium (DKTK) and Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany
4Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
5Bavarian Center for Cancer Research (BZKF), partner site Erlangen, Erlangen, Germany
6Department of Radiology, University Hospital, LMU Munich, Munich, Germany
7Department of Radiology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany
8Laboratory for Translational Cancer Immunology, Gene Center, LMU, Munich, Germany
9Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany
10Department of Nuclear Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany
11Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany
12German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Munich, Heidelberg, Germany
13Department of Medicine III (Hematology/Oncology), LMU University Hospital Munich, Muenchen, Germany

Lauren S Jiménez-Kurlander, MD1*, Gerald Behr, MD2*, Nancy J Bunin, MD3*, Ekaterina Doubrovina, MD, PhD4*, Rajani Dinavahi, MD5, Laurence Gamelin, MD, PhD5*, Armin Ghobadi, MD6, Leo Mascarenhas, MBBS, MD, MS7*, Sarah Nikiforow, MD, PhD8*, Richard J O'Reilly, MD4, Anita Price, MD2*, Barry Shulkin, MD9*, Ashok Srinivasan, MD10,11*, Stephanie Suser12*, Justin Wahlstrom, MD13*, Baodong Xing, PhD5* and Susan Prockop, MD1

1Department of Pediatrics, Boston Children's Hospital/Dana Farber Cancer Institute, Boston, MA
2Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY
3Cellular Therapy and Transplant Section, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
4Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
5Atara Biotherapeutics Inc., Thousand Oaks, CA
6Center for Gene and Cellular Immunotherapy (CGCI), Washington University School of Medicine, St. Louis, MO
7Children's Center for Cancer and Blood Diseases, Children's Hospital of Los Angeles, Los Angeles, CA
8Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
9Department of Diagnostic Imaging, St. Jude Children's Research Hospital, University of Tennessee Health Science Center, Memphis, TN
10Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN
11Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN
12Department of Pediatrics, BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY
13Atara Biotherapeutics, South San Francisco, CA

Daniel Fürst, MD1,2*, Christine Neuchel, PhD1,2*, Adela Neagoie, MD3*, Elisa Amann1,2*, Immanuel Rode, PhD1,2*, Angela Krauss1,2*, Hubert Schrezenmeier, MD1,2, Verena Wais, MD3*, Hartmut Döhner, MD3, Andreas Viardot, MD3 and Elisa Sala, MD3*

1Institute of Transfusion Medicine, University of Ulm, Ulm, Germany
2Institute of Clinical Transfusion Medicine and Immunohematology, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessia and University Hospital Ulm, Ulm, Germany
3Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany

Tassja J Spindler*, Fiona Ruiz*, Tiffany Jehng*, Hanna Ding*, Norma Guzman-Becerra, MS*, Shahram Khanzadeh*, Xiaoming Li*, Laurence Gamelin, MD, PhD*, Jason A. Dubovsky* and Cokey Nguyen*

Atara Biotherapeutics Inc., Thousand Oaks, CA

Ameya Shrinivas Kunte, MD1, Nico Gagelmann2*, Anita Badbaran2*, Carolina Berger3*, Radwan Massoud, MD1*, Evgeny Klyuchnikov1*, Christine Wolschke, MD1*, Dietlinde Janson, MD1*, Ulrike Fritsche-Friedland3*, Boris Fehse, PhD3*, Nicolaus Kroeger, MD1 and Francis A. Ayuk, MD1*

1Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
2University Medical Center Hamburg-Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany
3Department of Stem Cell Transplantation, Research Department Cell and Gene Therapy, University Medical Center Hamburg-Eppendorf, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Fareed Khawaja, MBBS1, Rishab Prakash, BS2*, Joseph Sassine, MD3*, Guy Handley, MD4*, Tracy VanWieren2*, Georgios Angelidakis2*, Swaminathan P. Iyer, MD5, Jeremy L. Ramdial, MD6, Sairah Ahmed, MD7, Yago Nieto, MD8, Amy Spallone2*, Ella J. Ariza-Heredia, MD9* and Roy Chemaly, MD, MPH10*

1Department of Infectious Diseases, MD Anderson Cancer Center, Houston, TX
2The University of Texas MD Anderson Cancer Center, Houston, TX
3Oklahoma University College of Medicine, Oklahoma City, OK
4University of South Florida Morsani College of Medicine, Tampa, FL
5Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Lymphoma/Myeloma and Stem Cell Transplantation, MD Anderson Cancer Center, Houston, TX
8Department of Stem Cell Transplantation and Cellular Therapy, UT M.D. Anderson Cancer Ctr., Houston, TX
9MD Anderson Cancer Center, Houston, TX
10Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX

Niels WCJ Van De Donk, MD1, Mounzer Agha2, Adam D Cohen, MD3, Yael C Cohen4*, Sébastien Anguille5*, Tessa Kerre6*, Wilfried W.H. Roeloffzen, MD, PhD7*, Deepu Madduri, MD8*, Jordan M Schecter9, Kevin C De Braganca9*, Carolyn C Jackson9*, Helen Varsos9*, Pankaj Mistry10*, Tito Roccia11*, Xiaoying Xu9*, Katherine Li12*, Enrique Zudaire12, Christina Corsale9*, Muhammad Akram13*, Dong Geng13*, Lida Pacaud13*, Pieter Sonneveld, MD14 and Sonja Zweegman, MD, PhD1

1Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
2UPMC Hillman Cancer Center, Pittsburgh, PA
3University of Pennsylvania, Philadelphia, PA
4Tel Aviv Sourasky (Ichilov) Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
5Vaccine and Infectious Disease Institute, University of Antwerp, Edegem, Belgium, Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Edegem, Belgium
6Ghent University Hospital, Ghent, Belgium
7University Medical Center Groningen, Groningen, Netherlands
8Mount Sinai Medical Center, New York, NY
9Janssen Research & Development, Raritan, NJ
10Janssen Research & Development, High Wycombe, United Kingdom
11Janssen Global Services, Raritan, NJ
12Janssen Research & Development, Spring House, PA
13Legend Biotech USA, Piscataway, NJ
14Erasmus Medical Center Cancer Institute, Rotterdam, Netherlands

Omar Alexis Castaneda Puglianini, MD1, Lauren C. Peres, PhD, MPH2*, Doris K. Hansen, MD3, Taiga Nishihori, MD3, Ariel F Grajales-Cruz, MD4, Brandon J. Blue, MD5, Jason Brayer, MD, PhD4, Ciara L. Freeman, MSc, FRCPath, MBBChir, MRCP1, Kenneth H. Shain, MD, PhD4, Hien D. Liu, MD3, Jose Ochoa, MD3, Frederick L. Locke, MD6, Rachid C. Baz, MD7 and Melissa Alsina, MD**8

1Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
2Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL
3Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
4Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
5Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
6H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
7Department of Malignant Hematology, Moffitt cancer center and research institute, tampa, FL
8Moffitt Cancer Center, Tampa, FL

Choquet Sylvain, MD1*, Magali Le Garff-Tavernier2*, Laetitia Souchet3*, Damien Roos Weil, MD, PhD4*, Veronique Morel, MD5*, Madalina Uzunov, MD6*, Carole Metz7*, Stephanie Nguyen Quoc, MDPC8*, Nathalie Jacque9*, Nicolas Gauthier, MD10*, Lise Willems, MD, PhD11*, Agathe Waultier, MD12*, Celia Salanoubat13*, Roch Houot, MD, PhD14*, Renata Ursu15*, Maryline Barrie16*, Guido Ahle, MD17*, Carole Soussain, MD18, Marion Alcantara, MD19* and Caroline Houillier, MD20*

1Clinical Hematology, La Pitie Salpetriere Hospital, APHP-Sorbonne Universite, Paris, France, France
2Sorbonne Université-INSERM UMRS 1138, AP-HP, Hopital Pitie-Salpetriere, Service d’Hématologie Biologique, Paris, France
3Pitie-Salpetriere Hospital - APHP Sorbonne Universite, Paris, France
4Hematology department, Sorbonne Université Hôpital Pitié Salpêtrière APHP, Paris, FRA
5Hematology Department, Pitié Salpétrière University Hospital, Paris, France
6Department of Hematology, University Hospital La Pitié SalpetrièRe, Paris, FRA
7Pharmacy, Groupe Hospitalier Pitié-salpêtrièRe, APHP, Paris, FRA
8Department of hematology, La Pitié University Hospital, Paris, France
9Service d'Hematologie Clinique, Hôpital Pitié Salpêtrière, APHP, Paris, France
10Service d’Hématologie, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France
11Assistance Publique-Hôpitaux de Paris.Centre-Université Paris Cité, Hôpital Cochin, Department of Hematology, Paris, France
12Department of Hematology, CHU Nimes, Nimes, France
13CH Sud Francilien, Hematology, CORBEIL ESSONNES, FRA
14Department of Hematology, Rennes University Hospital, Rennes, France
15Assistance Publique -hopitaux De Paris, Paris, FRA
16neuro oncology, AP hopitaux de Marseille, Marseille, France
17Neurology Department, CH Colmar, Colmar, France
18Hematology Department, Rene Huguenin Hospital, Institut Curie, Saint-Cloud, France
19Institut Curie, Paris, France
20LOC network, La Pitie Salpetriere Hospital, Assistance Publique Hopitaux de Paris, Paris, France

Jian-Qing Mi1*, Wanhong Zhao2*, Hongmei Jing3*, Weijun Fu4, Jianda Hu5, Lijuan Chen6*, Yiwen Zhang7*, Dan Yao8*, Hui Li8*, Jordan M Schecter9, Fan Yang8*, Huabin Sun9*, Sen Hong Zhuang8*, Da Xu7*, Tracy Luo7*, Xiaohu Fan10*, Ting Niu11, Jie Jin12 and Sai-Juan Chen1

1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, ShaanXi, Shanxi, China
3Peking University Third Hospital, Beijing, China
4Shanghai Changzheng Hospital and Department of Hematology, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, China
5Fujian Medical University Union Hospital, Fuzhou, Fujian, China
6Jiangsu Province Hospital, Nanjing, Jiangsu, China
7Legend Biotech China, Nanjing, Jiangsu, China
8Janssen China Research & Development, Shanghai, China
9Janssen Research & Development, Raritan, NJ
10Xi’an Jiaotong University Institute of Gene and Cell Therapy, Xi’an, ShaanXi, China
11West China Hospital of Sichuan University, Chengdu, China
12First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China

Mark P Hamilton, MD1,2,3, Felicia C Liu-Fei3*, Stefan K. Alig, MD4, John Tamaresis, PhD5*, Mohammad Shahrokh Esfahani, PhD6*, Zinaida Good, PhD3,5,7, Brian Sworder, MD, PhD8, Joseph Schroers-Martin, MD6, Chih Long Liu, PhD6*, Freja Tang Severinsen, BSc2,9*, Paul J Hanson, PhD3*, Ying Lu, PhD5*, Robert Lowsky, MD2, Robert S. Negrin, MD2, Everett H Meyer, MD, PhD2*, Melody Smith, MD, MS2, Sushma Bharadwaj, MD, MS10*, Judith A Shizuru, MD, PhD2,11, Surbhi Sidana, MD2,3, Parveen Shiraz, MD2, Andrew R. Rezvani, MD2, Laura J. Johnston, MD2, Wen-Kai Weng, MD, PhD2, Sally Arai, MD12, Lori Muffly, MD2,3, Saurabh Dahiya, MD2, Maximilian Diehn, MD, PhD13*, David M. Kurtz, MD, PhD6, Bita Sahaf, PhD3*, Crystal L. Mackall, MD3,7,14, Matthew J Frank, MD, PhD15, David B. Miklos, MD, PhD2,3 and Ash A. Alizadeh, MD, PhD11,16

1Divisions of Oncology and Hematology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA
2Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA
3Center for Cancer Cell Therapy, Stanford University School of Medicine, Stanford, CA
4Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
5Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA
6Divisions of Oncology and Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
7Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
8Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
9Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, AL, Denmark
10Division of BMT and Cellular Therapy, Stanford University, Stanford, CA
11Institute for Stem Cell Biology and Regenerative Medicine, Stanford University Medical Center, Stanford, CA
12Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University Medical Center, Stanford, CA
13Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
14Divisions of Hematology and Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA
15Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA
16Divisions of Oncology and Hematology, Department of Medicine, Stanford University School of Medicine, San Mateo, CA

Peihao Zheng, MD1*, Rui Liu2*, Teng Xu3*, Fan Yang2*, Shaomei Feng, MD1*, Yuelu Guo, MD1*, Lixia Ma, MD1*, Hui Shi, MD1*, Hongwei Yu3*, Biping Deng4*, Xiaoyan Ke, MD, PHD1* and Kai Hu, M.D., Ph.D.1*

1Department of Adult Lymphoma, Beijing GoBroad Boren Hospital, Beijing, China
2Department of Adult Lymphoma, Beijing GoBroad Boren Hospital, Beijing, AL, China
3Department of Data Statistics, Beijing GoBroad Boren Hospital, Beijing, China
4Cytology Laboratory, Beijing GoBroad Boren Hospital, Beijing, China

Belén Sierro*, Clara Beatriz Garcia-Calderon, PhD*, Luzalba Sanoja-Flores, PhD*, Victoria Ruiz-Maldonado*, Javier Delgado Serrano, MD*, Agueda Molinos-Quintana*, Juan Luis Reguera, MD*, Beatriz Guijarro-Albaladejo*, Marta Reinoso-Segura*, Estefania Garcia-Guerrero, PhD*, Jose A. Perez-Simon, MD, PhD and Teresa Caballero, PhD*

Instituto de Biomedicina de Sevilla (IBiS), UGC-Hematología, Hospital Universitario Virgen del Rocío/ CSIC/ CIBERONC, Universidad de Sevilla, Sevilla, Spain

*signifies non-member of ASH